Mimuro J, Muramatsu S, Maekawa H, Sakata Y, Kaneko M, Yoshitake S, Okuma M, Ito Y, Takeda Y, Matsuda M
Division of Hemostasis and Thrombosis Research, Jichi Medical School, Tochigi-Ken, Japan.
Int J Hematol. 1992 Oct;56(2):129-34.
In four abnormal fibrinogens with a point mutation in the gamma chain, all characterized by impaired fibrin polymerization, we identified single base exchanges in the respective mutant gamma chain genes by polymerase chain reaction followed by DNA sequence analysis. These base exchanges accounted for the amino acid substitutions previously reported from our laboratory. They were exchanges of C to T (CGC for gamma Arg-275 to TGC for Cys) in fibrinogen Osaka II, T to G (AAT for gamma Asn-308 to AAG for Lys) in fibrinogen Kyoto I, T to C (ATG for gamma Met-310 to ACG for Thr) in fibrinogen Asahi, and G to T (GAT for gamma Asp-330 to TAT for Tyr) in fibrinogen Kyoto III. These base exchanges were found to reside in exon VIII of the gamma chain gene. Since many abnormal molecules are associated with polymerization defects, unless associated with the impaired release of fibrinopeptides A and/or B, exon VIII of the gamma chain gene may deserve careful study to define the structural alterations.
在4种γ链存在点突变的异常纤维蛋白原中,所有这些纤维蛋白原的特征均为纤维蛋白聚合受损,我们通过聚合酶链反应,随后进行DNA序列分析,在各自的突变γ链基因中鉴定出单碱基交换。这些碱基交换与我们实验室之前报道的氨基酸取代相符。它们分别是:大阪II型纤维蛋白原中C突变为T(γ链第275位精氨酸的CGC突变为半胱氨酸的TGC);京都I型纤维蛋白原中T突变为G(γ链第308位天冬酰胺的AAT突变为赖氨酸的AAG);旭日式纤维蛋白原中T突变为C(γ链第310位甲硫氨酸的ATG突变为苏氨酸的ACG);京都III型纤维蛋白原中G突变为T(γ链第330位天冬氨酸的GAT突变为酪氨酸的TAT)。这些碱基交换位于γ链基因的第VIII外显子。由于许多异常分子与聚合缺陷相关,除非与纤维蛋白肽A和/或B的释放受损有关,否则γ链基因的第VIII外显子可能值得仔细研究以确定结构改变。